Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells

Life Sciences

Volumn 81, Issue 8, 2007, Pages 664-672

  Liou, Horng Huei ^a,b   Hsu, Hao Jui ^a   Tsai, Yuan Feen ^a   Shih, Chin Yu ^a   Chang, Yu Chia ^a   Lin, Chun Jung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ARBEC; BBB; MPP+; MPTP; Nicotine; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DECYNIUM 22; NICOTINE; ORGANIC CATION TRANSPORTER 1; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; MOLECULAR INTERACTION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALGORITHMS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; COTININE; DATA INTERPRETATION, STATISTICAL; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; ENDOTHELIAL CELLS; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; MPTP POISONING; NICOTINE; NICOTINIC AGONISTS; NONLINEAR DYNAMICS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 34547940290     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.07.004     Document Type: Article

References (44)

1. Abercrombie E.D., and Finaly J.M. Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-CE. In: Robinson T.E., and Justice Jr. J.B. (Eds). Microdialysis in the Neuroscience (1991), Elsevier, Amsterdam 253-274
2. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 10 (2003) 256-259
3. Busch A.E., Quester S., Ulzheimer J.C., Gorboulev V., Akhoundova A., Waldegger S., Lang F., and Koepsell H. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Letters 395 (1996) 153-156
4. Chang Y.L., Tsai P.L., Chou Y.C., Tien J.H., and Tsai T.H. Simultaneous determination of nicotine and its metabolite, cotinine, in rat blood and brain tissue using microdialysis coupled with liquid chromatography: pharmacokinetic application. Journal of Chromatography A 1088 (2005) 152-157
5. Cormier A., Morin C., Zini R., Tillement J.P., and Lagrue G. Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology 44 (2003) 642-652
6. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
7. Friedrich A., George R.L., Bridges C.C., Prasad P.D., and Ganapathy V. Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4). Biochimica et Biophysica Acta 1512 (2001) 299-307
8. Fukada A., Saito H., and Inui K.-I. Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2. Journal of Pharmacology and Experimental Therapeutics 302 (2002) 532-538
9. Garberg P., Ball M., Borg N., Cecchelli R., Fenart L., Hurst R.D., Lindmark T., Mabondzo A., Nilsson J.E., Raub T.J., Stanimirovic D., Terasaki T., Oberg J.O., and Osterberg T. In vitro models for the blood-brain barrier. Toxicology in Vitro 19 (2005) 299-334
10. Grasbon-Frodl E.M., Kosel S., Sprinzl M., Von Eitzen U., Mehraein P., and Graeber M.B. Two novel point mutations of mitochondrial t-RNA genes in histologically confirmed Parkinson disease. Neurogenetics 2 (1999) 121-127
11. Hukkanen J., Jacob III P., and Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacological Reviews 57 (2005) 79-115
12. Javitch J.A., D'Amato J.R., Strittmatter S.M., and Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proceedings of the National Academy of Sciences of the United States of America 82 (1985) 2173-2177
13. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
14. Kösel S., Grasbon-Frodl E.M., Mautsch U., Egensperger R., von Eitzen U., Frishman D., Hofmann S., Gerbitz K.D., Mehraein P., and Graeber M.B. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics 1 (1998) 197-204
15. Kunugi H., Nanko S., Ueki A., Otsuka E., Hattori M., and Hoda F. High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neuroscience Letters 221 (1997) 202-204
16. Kurth J.H., Kurth M.C., Poduslo S.E., and Schwankhaus J.D. Association of a monoamine oxidase B allele with Parkinson's disease. Annals of Neurology 33 (1993) 368-372
17. Langston J.W., Ballard P.A., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
18. Liou H.H., Tsai M.C., Chen C.J., Jeng J.S., Chang Y.C., Chen S.Y., and Chen R.C. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48 (1997) 1583-1588
19. Lockman P.R., McAfee G., Geldenhuys W.J., Van der Schyf C.J., and Abbruscato T.J. Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure. Journal of Pharmacology and Experimental Therapeutics 314 (2005) 636-642
20. Maggio R., Riva M., Vaglini F., Fornai F., Molteni R., Armogida M., Racagni G., and Corsini G.U. Nicotine prevents experimental Parkinsonism in rodents and induces striatal increase of neurotrophic factors. Journal of Neurochemistry 71 (1998) 2439-2446
21. Malaiyandi V., Sellers E.M., and Tyndale R.F. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clinical Pharmacology and Therapeutics 77 (2005) 145-158
22. Martel F., Vetter T., Russ H., Gründemann D., Azevedo I., Koepsell H., and Schömig E. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn-Schmiedeberg's Archives of Pharmacology 354 (1996) 320-326
23. + in an immortalized rat brain microvessel endothelial cell line (RBE4). Naunyn-Schmiedeberg's Archives of Pharmacology 363 (2001) 1-10
24. Murrin L.C., Ferrer J.R., Wanyun Z., and Haley N.J. Nicotine administration to rats: methodological considerations. Life Sciences 40 (1987) 1699-1708
25. Nakayama H., Okuda H., Nakashima T., Imaoka S., and Funae Y. Nicotine metabolism by rat hepatic cytochrome P450s. Biochemical Pharmacology 45 (1993) 554-2556
26. Naoi M., Takahashi T., and Nagatsu T. A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatography. Analytical Biochemistry 162 (1987) 540-545
27. Naoi M., Maruyama W., Dostert P., Hashizume Y., Nakahara D., Takahashi T., and Ota M. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Research 709 (1996) 285-295
28. Niwa T., Takeda N., Yoshizumi H., Tatematsu A., Yoshida M., Dostert P., Naoi M., and Nagatsu T. Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in Parkinsonian brain. Advances in Neurology 60 (1993) 234-237
29. Obata T., Aomine M., Inada T., and Kinemuchi H. Nicotine suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum. Neuroscience Letters 330 (2002) 122-124
30. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fifth ed (2005), Elsevier, Academic Press, Sydney
31. Polymeropoulos M.H., Lavedan C., Leroy E., Idel S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
32. + levels in mice. Brain Research 917 (2001) 219-224
33. Riachi N.J., Lamanna J.C., and Harik S.I. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain. Journal of Pharmacology and Experimental Therapeutics 249 (1989) 744-748
34. Riah O., Courrière P., Dousset J.C., Todeschi N., and Labat C. Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats. Cellular and Molecular Neurobiology 18 (1998) 311-318
35. Rosenberg J., Benowitz N.L., Jacob P., and Wilson K.M. Disposition kinetics and effects of intravenous nicotine. Clinical Pharmacology and Therapeutics 28 (1980) 517-522
36. Takami K., Saito H., Okuda M., Takano M., and Inui K.-I. Distinct characteristics of transcellular transport between nicotine and tetraethylammonium in LLC-PK1 cells. Journal of Pharmacology and Experimental Therapeutics 286 (1998) 676-680
37. Todd M.M., and Weeks J. Comparative effects of propofol, pentobarbital, and isoflurane on cerebral blood flow and blood volume. Journal of Neurosurgical Anesthesiology 8 (1996) 296-303
38. Tomiyama Y., Brian J.E., and Todd M.M. Cerebral blood flow during hemodilution and hypoxia in rats. Role of ATP-sensitive potassium channels. Stroke 30 (1999) 1942-1948
39. Whishaw I.Q., Cioe J.D.D., Previsich N., and Kolb B. The variability of the interaural line vs the stability of bregma in rat stereotaxic surgery. Physiology and Behavior 19 (1977) 719-722
40. Wintermeyer P., Kruger R., Kuhn W., Muller T., Woitalla D., Berg D., Becker G., Leroy E., Polymeropoulos M., Berger K., Przuntek H., Schols L., Epplen J.T., and Riess O. Mutation analysis and association study of UCHL1 gene in German Parkinson disease patients. Neuroreport 11 (2000) 2079-2082
41. Wong L.T.Y., Smyth D.D., and Sitar D.S. Interference with renal organic cation transport by (-)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers. Journal of Pharmacology and Experimental Therapeutics 261 (1992) 21-25
42. Yeh W.L., Lu D.Y., Lin C.J., Liou H.C., and Fu W.M. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1a accumulation and VEGF expression. Molecular Pharmacology 72 (2007) 440-449
43. Yoshida M., Niwa T., and Nagatsu T. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes. Neuroscience Letters 119 (1990) 109-113
44. Zevin S., Schaner M.E., and Giacomini K.M. Nicotine transport in a human choriocarcinoma cell line (JAR). Journal of Pharmaceutical Sciences 87 (1998) 702-706